amdavis@cooley.com
Alexander Davis represents public and private companies in a wide range of corporate and securities matters, including private financings, public offerings, SEC reporting and mergers & acquisitions.
Download full bio
Archer to Combine With SPAC Atlas Crest Investment
Inhibrx – $137 Million IPO
ALX Oncology – $186 Million IPO
Avidity Biosciences - $289 Million IPO
The Underwriters On Guardant Health's $1.1 Billion Follow-On Offering
View all
Public Companies
Capital Markets
Emerging Companies
Mergers & Acquisitions
Venture Capital
Columbia Law SchoolJD, 2017
San Diego State UniversityBS, Financemagna cum laude, 2014
California
Archer to Combine With SPAC Atlas Crest Investment March 10, 2021
Gossamer Bio – $317 Million IPO February 21, 2019
Taiwan Liposome Company Completes US IPO January 3, 2019
State Bar of California
San Diego County Bar Association
+1 858 550 6113
Locations